ISPOR - HTA19 How Are United States ICER’S Evidence Ratings Determined? A Systematic Review of ICER’S Evidence Ratings in Evidence Reports for New Drugs in 2020 and 2021

HTA19 How Are United States ICER’S Evidence Ratings Determined? A Systematic Review of ICER’S Evidence Ratings in Evidence Reports for New Drugs in 2020 and 2021

Abstract

Authors

N Ronquest M Clinkscales K Paret

Full Text Cite This Article

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now